Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

AMED - Amedisys Inc Stock Price, Fair Value and News

$343.90+0.50 (+0.15%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

AMED Price Action

Last 7 days

-0.3%

Last 30 days

1.3%

Last 90 days

9.1%

Trailing 12 Months

18.2%

AMED RSI Chart

2025FebMarAprMayJunJulAugSepOct2030405060708090100

AMED Valuation

Market Cap

11.3B

Price/Earnings (Trailing)

131.89

Price/Sales (Trailing)

4.7

EV/EBITDA

58.15

Price/Free Cashflow

48.05

AMED Price/Sales (Trailing)

201420162018202020222024012345

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AMED Fundamentals

AMED Revenue

Revenue (TTM)

2.4B

Rev. Growth (Yr)

5.19%

Rev. Growth (Qtr)

4.55%

20102015202020251B1.5B2B2.5B

AMED Earnings

Earnings (TTM)

85.6M

Earnings Growth (Yr)

-13.06%

Earnings Growth (Qtr)

-53.97%

2010201520202025-400M-300M-200M-100M0100M200M

AMED Profitability

EBT Margin

6.21%

Return on Equity

6.95%

Return on Assets

3.87%

Free Cashflow Yield

2.08%

AMED Investor Care

Shares Dilution (1Y)

0.45%

Diluted EPS (TTM)

2.57

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
20122014201620182020202220241.2B1.4B1.6B1.8B2B2.2B2.4B
Net sales
YearQ1Q2Q3Q4
20252.4B2.4B00
20242.3B2.3B2.3B2.3B
20232.2B2.2B2.2B2.2B
20222.2B2.2B2.2B2.2B
20212.1B2.2B2.2B2.2B
20202.0B2.0B2.0B2.1B
20191.7B1.8B1.9B2.0B
20181.5B1.6B1.6B1.7B
20171.5B1.5B1.5B1.5B
20161.3B1.4B1.4B1.4B
20151.2B1.2B1.2B1.3B
20141.2B1.2B1.2B1.2B
20131.4B1.4B1.3B1.2B
20121.5B1.5B1.5B1.4B
20111.6B1.5B1.5B1.5B
2010001.6B1.6B
Get all data in R, Python etc through our Historical Stock Data APIs

About Amedisys Inc

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
 CEO
 WEBSITEamedisys.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES20000

Amedisys Inc Frequently Asked Questions

What is the ticker symbol for Amedisys Inc? What does AMED stand for in stocks?

AMED is the stock ticker symbol of Amedisys Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Amedisys Inc (AMED)?

As of Fri Oct 31 2025, market cap of Amedisys Inc is 11.29 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMED stock?

You can check AMED's fair value in chart for subscribers.

Is Amedisys Inc a good stock to buy?

The fair value guage provides a quick view whether AMED is over valued or under valued. Whether Amedisys Inc is cheap or expensive depends on the assumptions which impact Amedisys Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMED.

What is Amedisys Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Oct 31 2025, AMED's PE ratio (Price to Earnings) is 131.89 and Price to Sales (PS) ratio is 4.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMED PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Amedisys Inc's stock?

In the past 10 years, Amedisys Inc has provided 0.083 (multiply by 100 for percentage) rate of return.